Latent classes of symptom trajectories among major depressive disorder patients in China
Yufei Wang,Jiarui Li,Wen Bian,Yanping Duan,Wenqi Geng,Jing Jiang,Xiaohui Zhao,Tao Li,Yinan Jiang,Lili Shi,Jinya Cao,Gang Zhu,Kerang Zhang,Qiaoling Chen,Hongjun Tian,Xueyi Wang,Nan Zhang,Gang Wang,Jing Wei,Xin Yu
DOI: https://doi.org/10.1016/j.jad.2024.01.144
IF: 6.533
2024-01-26
Journal of Affective Disorders
Abstract:Objective This study aimed to understand the long-term symptom trajectories of Chinese patients with major depressive disorder (MDD) using piecewise latent growth modeling and growth mixture modeling. The investigation also aimed to identify the baseline characteristics indicative of poorer treatment outcomes. Methods A total of 558 outpatients with MDD were assessed using a sequence of surveys. The Hamilton Rating Scale for Depression (HRSD), Hamilton Anxiety Rating Scale (HAMA), and Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) were used to evaluate baseline depression, anxiety, and cognitive function. Depression symptom severity was subsequently measured at the 1-month, 2-month, 6-month, 1-year, and 2-year follow-ups. Results Results indicated three depressive symptomology trajectories, including (a) severe, improving class (12.72 %), (b) partially responding, later deteriorating class (6.09 %), and (c) moderate, improving class (81.18 %). Logistic regression analyses showed that a history of cardiovascular disease (CVD) increased the odds of belonging to the partially responding, later deteriorating class, whereas higher baseline depression increased the odds of belonging to the severe, improving class compared to the moderate, improving class. Patients who experienced less depression relief during the first month of treatment had a lower probability of belonging to the moderate, improving class. Limitations Participant attrition in this study may have inflated the estimated rate of treatment-resistant patients. Conclusions The burden of CVD and poorer initial treatment response are plausible risk factors for poorer treatment outcomes, highlighting targets for intervention in Chinese MDD patients.
psychiatry,clinical neurology